These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 25641318)
1. Can the signal-to-noise ratio of choline in magnetic resonance spectroscopy reflect the aggressiveness of endometrial cancer? Han X; Kang J; Zhang J; Xiu J; Huang Z; Yang C; Sun X; Fu C; Liu Q Acad Radiol; 2015 Apr; 22(4):453-9. PubMed ID: 25641318 [TBL] [Abstract][Full Text] [Related]
2. Can magnetic resonance spectroscopy differentiate endometrial cancer? Zhang J; Cai S; Li C; Sun X; Han X; Yang C; Fu C; Liu Q; Xin Y; Zong Y Eur Radiol; 2014 Oct; 24(10):2552-60. PubMed ID: 24903228 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of breast cancer using proton MR spectroscopy: total choline peak integral and signal-to-noise ratio as prognostic indicators. Shin HJ; Baek HM; Cha JH; Kim HH AJR Am J Roentgenol; 2012 May; 198(5):W488-97. PubMed ID: 22528931 [TBL] [Abstract][Full Text] [Related]
4. Assessment of therapeutic response of locally advanced breast cancer (LABC) patients undergoing neoadjuvant chemotherapy (NACT) monitored using sequential magnetic resonance spectroscopic imaging (MRSI). Danishad KK; Sharma U; Sah RG; Seenu V; Parshad R; Jagannathan NR NMR Biomed; 2010 Apr; 23(3):233-41. PubMed ID: 20175134 [TBL] [Abstract][Full Text] [Related]
5. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors. Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615 [TBL] [Abstract][Full Text] [Related]
6. In vivo MR spectroscopy predicts high tumor grade in endometrial cancer. Ytre-Hauge S; Esmaeili M; Sjøbakk TE; Grüner R; Woie K; Werner HM; Krakstad C; Bjørge L; Salvesen ØO; Stefansson IM; Trovik J; Bathen TF; Haldorsen IS Acta Radiol; 2018 Apr; 59(4):497-505. PubMed ID: 28927296 [TBL] [Abstract][Full Text] [Related]
7. Breast Magnetic Resonance Spectroscopy at 3 T in Biopsy-Proven Breast Cancers: Does Choline Peak Correlate With Prognostic Factors? Galati F; Luciani ML; Caramanico C; Moffa G; Catalano C; Pediconi F Invest Radiol; 2019 Dec; 54(12):767-773. PubMed ID: 31356383 [TBL] [Abstract][Full Text] [Related]
8. Three-dimensional proton MR spectroscopic imaging at 3 T for the differentiation of benign and malignant breast lesions. Gruber S; Debski BK; Pinker K; Chmelik M; Grabner G; Helbich T; Trattnig S; Bogner W Radiology; 2011 Dec; 261(3):752-61. PubMed ID: 21998046 [TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance spectroscopy of premalignant and malignant endometrial disorders: a feasibility of in vivo study. Celik O; Hascalik S; Sarac K; Meydanli MM; Alkan A; Mizrak B Eur J Obstet Gynecol Reprod Biol; 2005 Feb; 118(2):241-5. PubMed ID: 15653212 [TBL] [Abstract][Full Text] [Related]
10. Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors. Zhang J; Cheng K; Ding Y; Liang W; Ding Y; Vanel D; Cheng X Eur J Radiol; 2013 Dec; 82(12):2124-8. PubMed ID: 22169357 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values. Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403 [TBL] [Abstract][Full Text] [Related]
12. Determination of choline concentration in breast lesions: quantitative multivoxel proton MR spectroscopy as a promising noninvasive assessment tool to exclude benign lesions. Dorrius MD; Pijnappel RM; Jansen-van der Weide MC; Jansen L; Kappert P; Oudkerk M; Sijens PE Radiology; 2011 Jun; 259(3):695-703. PubMed ID: 21460033 [TBL] [Abstract][Full Text] [Related]
13. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Bartella L; Morris EA; Dershaw DD; Liberman L; Thakur SB; Moskowitz C; Guido J; Huang W Radiology; 2006 Jun; 239(3):686-92. PubMed ID: 16603660 [TBL] [Abstract][Full Text] [Related]
14. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience. Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465 [TBL] [Abstract][Full Text] [Related]
15. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner. Kuo YT; Li CW; Chen CY; Jao J; Wu DK; Liu GC J Magn Reson Imaging; 2004 May; 19(5):598-604. PubMed ID: 15112309 [TBL] [Abstract][Full Text] [Related]
16. Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy. Fayad LM; Barker PB; Jacobs MA; Eng J; Weber KL; Kulesza P; Bluemke DA AJR Am J Roentgenol; 2007 Jun; 188(6):1513-20. PubMed ID: 17515370 [TBL] [Abstract][Full Text] [Related]
17. In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging. Zou QG; Xu HB; Liu F; Guo W; Kong XC; Wu Y Clin Radiol; 2011 Oct; 66(10):953-60. PubMed ID: 21663899 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of cerebral glioma grade by using normal side creatine as an internal reference in multi-voxel 1H-MR spectroscopy. Yerli H; Ağildere AM; Ozen O; Geyik E; Atalay B; Elhan AH Diagn Interv Radiol; 2007 Mar; 13(1):3-9. PubMed ID: 17354186 [TBL] [Abstract][Full Text] [Related]
19. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings. Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768 [TBL] [Abstract][Full Text] [Related]
20. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. Stadlbauer A; Gruber S; Nimsky C; Fahlbusch R; Hammen T; Buslei R; Tomandl B; Moser E; Ganslandt O Radiology; 2006 Mar; 238(3):958-69. PubMed ID: 16424238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]